Most recent articles by:
Pavlos Giorkas
Pavlos Giorkas is a blogger and content creator with a passion for crypto, health, consumer tech and money management. He's been dealing with cryptocurrency since 2013 but didn't take action until 3 years later on 2016. On Bitnewsbot he covers the latest news in the crypto space.
News
Ripple CTO David Schwartz Retires, Misses Out on $72M XRP Surge
David Schwartz steps down from daily duties as CTO of Ripple.Schwartz has been involved with the XRP Ledger project since 2011.He sold much of...
News
Tokenization Brings Luxury Assets to Everyone Through Blockchain
Blockchain technology is making alternative assets like art, wine, and watches accessible to more investors through tokenization.The real-world asset (RWA) market has increased 380%...
News
Gold Surges as De-Dollarization Remains Elusive in Global Trade
The U.S. dollar remains dominant in global finance despite a decline in America’s share of the world economy.
Gold has seen rising demand, with central...
News
Tesla Hikes Model Y Lease Prices After $7,500 EV Tax Credit Ends
Tesla increased lease prices for its Model Y and Model 3 vehicles in the United States after the expiration of a federal EV tax...
News
Bitcoin Core Maintainers Reverse OP_RETURN Datacarrier Deprecation
Bitcoin Core developers reversed a plan to remove user control over OP_RETURN’s datacarriersize hours before releasing version 30.The change means node operators can still...
News
BitMEX CEO: DEX Hype May Fade as Incentive Models Prove Fragile
Competition is increasing among decentralized exchanges (DEXs) in the perpetual trading sector, with new platforms challenging current leaders.Bitmex CEO Stephan Lutz warns that many...
News
BRICS Accelerates Dollar Alternatives With Gold, New Payment Systems
BRICS nations are intensifying efforts to reduce reliance on the U.S. dollar by building new financial infrastructure.
The bloc holds over 6,000 tons of Gold,...
News
Pfizer Shares Jump After Trump Deal for Discounted Drug Sales
Pfizer reached an agreement with the U.S. government to offer major prescription drugs at steep discounts through a new federal online platform.
The deal led...
